Skip to main content

Peer Review reports

From: Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

Original Submission
7 Jun 2022 Submitted Original manuscript
27 Jul 2022 Author responded Author comments - Kim van den Berg
Resubmission - Version 2
27 Jul 2022 Submitted Manuscript version 2
Publishing
29 Jul 2022 Editorially accepted
6 Sep 2022 Article published 10.1186/s12885-022-09947-w

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us